Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Treasury Shares (2009 - 2025)

Grifols' (GIFLF) quarterly Treasury Shares came in at -$152.5 million in Q4 2025, down 5.7% on a YoY basis from -$161.7 million in Q4 2024, and down 5.7% quarter-over-quarter from -$144.3 million in Q4 2024.

Analysis

Grifols (GIFLF) Treasury Shares (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Treasury Shares for 17 consecutive years, with -$152.5 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 5.7% year-over-year to -$152.5 million; the trailing twelve-month figure through Dec 2025 stood at -$152.5 million (down 5.7% YoY), and the FY2025 full-year result was -$148.0 million, down 2.6% from the prior year.
  • Treasury Shares eased to -$152.5 million in Q4 2025 per GIFLF's latest filing, from -$144.3 million in the prior quarter.
  • Across five years, Treasury Shares topped out at -$144.3 million in Q4 2024 and bottomed at -$187.8 million in Q4 2021.
  • Historically, Treasury Shares has averaged -$162.9 million across 5 years, with a median of -$164.3 million in 2023.
  • The sharpest annual moves came in 2021 and 2024: Treasury Shares plunged 260.21% in 2021, then gained 12.22% in 2024.
  • Over 5 years, Treasury Shares stood at -$187.8 million in 2021, then rose by 11.88% to -$165.5 million in 2022, then increased by 0.7% to -$164.3 million in 2023, then rose by 12.22% to -$144.3 million in 2024, then retreated by 5.7% to -$152.5 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods registered -$152.5 million, -$144.3 million, and -$164.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -152.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -152.49 Mn
Dec 31, 2025 -152.49 Mn
Dec 31, 2024 -144.26 Mn
Dec 31, 2024 -144.26 Mn
Dec 31, 2023 -164.35 Mn
Dec 31, 2023 -164.35 Mn
Dec 31, 2022 -165.50 Mn
Dec 31, 2022 -165.50 Mn
Dec 31, 2021 -187.83 Mn
Dec 31, 2021 -187.83 Mn
Dec 31, 2020 -52.14 Mn
Dec 31, 2020 -52.14 Mn
Sep 30, 2020 -51.08 Mn
Sep 30, 2020 -51.08 Mn
Mar 31, 2020 -54.21 Mn
Mar 31, 2020 -54.21 Mn
Dec 31, 2019 -54.88 Mn
Dec 31, 2019 -54.88 Mn
Sep 30, 2019 -55.17 Mn
Sep 30, 2019 -55.17 Mn